selected scholarly activity
-
conferences
- CODE RESEARCH!: A SINGLE CENTRE'S EXPERIENCE ON DEVELOPING A HYPERACUTE STROKE RESEARCH RECRUITMENT MODEL. International Journal of Stroke. 179-179. 2018
- QUALITY IMPROVEMENTS-EVALUATION OF KEY PERFORMANCE INDICATORS FOR STROKE STUDIES CONDUCTED AT A LARGE TEACHING HOSPITAL OVER 3 YEARS. International Journal of Stroke. 176-177. 2018
- Rapid Evolution of Cerebral Micro bleeds in Reversible Cerebral Vasospasm Syndrome. International Journal of Stroke. 56-56. 2016
- Cerebral Vasospasm and Delayed Cerebral Ischemia in Subarachnoid Hemorrhage: a Contemporary Case Series. Stroke. E208-E209. 2013
-
journal articles
- Dabigatran following acute transient ischemic attack and minor stroke II (DATAS II). International Journal of Stroke. 12:910-914. 2017
- Clinical Implications of Reversal Agents for Direct Oral Anticoagulants. Future Cardiology. 13:153-159. 2017
- Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial. Age and Ageing. 45:77-83. 2016
- What's New in Stroke? Phase III Randomized Clinical Trials of 2012–2014. International Journal of Stroke. 10:790-795. 2015
- Stroke prevention in asymptomatic carotid artery disease: revascularization of carotid stenosis is not the solution. Polskie Archiwum Medycyny Wewnetrznej. 125:363-369. 2015
- Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants. Cardiology and Therapy. 2:135-149. 2013